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Conclusion: A significant “umber of &al lesions with angiographic stenosis> 70% an? 
associated with a physiologic nonischemic threshold (i.e. FFR -> 0.75). Ostial lesions 
without evidence of ischemia should undergo physiologic testing before interventions. 
Ostial Lesions: Angiography vs FFR 
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Background: Cutting balloon atherotomy (CBA) achieves luminal gain by creating con- 
trolled fissuring of coronary plaques. In a retrospective comparison of CBA to other tech- 
niques for treatment of non-intrastent lesions at Barnes-Jewish Hospital, CBA was 
associated with decreased need for stent implantation (50% vs. 66.4%), greater angio- 
graphic and clinical success (99.6% vs. 97.9% and 99.3% vs. 95.9%), and no difference 
in 1 and 9 month target vessel revascularization (TVR) (1.6% vs. 0.9%, and 15% vs. 
12%, respectively). The Cuffing Balloon as Sole Revascularization Trial compares CBA 
with conventional balloon angioplasty (POBA) as the primary treatment for non-intrastent 
lesions. Methods: Patients undergoing percutaneous revascularization for native coro- 
nary artery lesions are randomized to CBA or POBA as primary treatment. Provisional 
stenting is indicated for z-35% residual stenosis, grade B or greater dissection, or throm- 
bus. The primary endpoint is stent implantation for sub-optimal results. Secondary end- 
points include in-hospital MACE and 1 and 9 month TLR. Results: Twenty-two patients 
have been randomized to the CBA group and 17 patients to the POBA group. Clinical 
characteristics. vessels treated, and lesion types are similar between the two groups. To 
date, CBA has achieved greater angiographic success as primary therapy (67.0% vs. 
57.7%; p=O.O2), with fewer dissections (22.2% vs. 45.5%, p=NS) compared to conven- 
tional angioplasty. CBA is associated a decreased need for stent implantation (27.6% vs. 
61.6%; p<O.OOl). Despite lower stent utilization in the CBA group, there is no difference 
in final stenosis (14.5% vs. 14.0%). 
Conclusions: As primary therapy, CBA appears to achieve greater angiographic suc- 
cess with decreased need for stent implantation compared to POBA. Updated enrollment 
with cost analysis, 1 month and 9 month outcomes will be presented. A model for com- 
paring cost-benefit of CBA compared to implantation of drug-coated stents will be dis- 
cussed. 
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Background: Increased CK-MB release after percutaneous coronary intervention (PCI) 
is associated with increased mortality. It is not known if the prognosis of diabetic (D) pts 
with increased CK-MB levels after PCI is different than nondiabetic (ND) pts. 
Methods: The GUARDIAN trial contained 2,173 PCI pts who had prospectively acquired 
baseline clinical and post-PC1 CK-MB and ECG data. The incidence and B-month mortal- 
ity associated with different levels of CK-MB were compared between 516 D pts and 
1,657 ND pts. 
Results: The incidence of peak CK-MB elevation in D pts was not greater than in ND pts 
(table). The D subgroup was older (median age 64.0 vs. 62.0, p.zO.05); had more females 
(33.3% vs. 22.7%, p<O.OOl) and fewer whites (66.6% vs. 94.5%, p<O.OOl); was more 
obese (media” body mass index 29.0 vs. 27.3. p<O.OOl): had a higher systolic blood 
pressure (median 134.0 vs. 130.0, p<O.OOl); and was more likely to have a history of 
heart failure (15.7% vs. 7.0%. pcO.OOl), cerebrovascular disease (11.4% vs. 6.0%, 
p<O.O5), and peripheral vascular disease (16.0% vs. 9.6%. pcO.001) than the ND sub- 
group. The 6-month mortality rates in D were usually slightly greater than in ND at any 
particular peak CK-MB ratio cutoff, but “one were statistically significant (table). 
Conclusion: The incidence and magnitude of CK-MB leaks following PCI is no greater in 
D than in ND. D have a more adverse risk profile than ND, but for any given level of peak 
CK-MB release post-PCI, diabetes does not significantly elevate 6-month mortality risk. 
Incidence of Peak CK-MB Ratio in PCI 6-Month Mortality in PCI Patients by Peak 
Patients (%) CK-MB Ratio Cutoffs (%) 
<l 51<3 z33<5 s >I0 <1 ULN >3ULN >5ULN >lOULN 
UL ULN ULN <lO ULN 
N ULN 
Diabeti 67. 21.3 5.0 2.9 2.9 3.1 3.6 6.7 6.7 
c 6 
Non- 63. 23.5 5.7 3.7 3.1 1.4 3.6 5.3 5.9 
diabeti 9 
c 
p=o.57 p=o.c6 p=1.00 p=1.00 p=l.OO 
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Background: Patients (pts) with a history of prior percutaneous coronary revasculariza- 
tion (PCR) are often excluded from clinical trials. As a result, there is limited data on the 
outcome of these pts undergoing repeat coronary intervention. 
Method: Of 11,262 pts undergoing percutaneous coronary intervention (PCI) in the Pre- 
vention of Restenosis with Tranilast and its Outcomes (PRESTO) trial, 3,495 pts had his- 
tory of prior PCR, 2l3 of whom had prior stent placement. We compared the outcome of 
these pts with 7,767 pts with de “ova lesions. 
Results: Mean age was 60 yrs in both groups. Pts with prior PCR were more likely to 
have DM (26% vs 22%, P < O.OOl), HTN (70% vs 57%, p < O.OOl), hypercholesterolemia 
(66% vs 47%. p < O.OOl), prior Ml (56% vs 31%, p < O.OOl), and prior CABG (23% vs 
9%, p < O.OOl), and less likely to have new-onset angina (21% vs 26%, p < O.OOl), signif- 
icant EKG changes (6% vs ll%, p < O.OOl), or be current smokers (17% vs 25%, p < 
0.001). Angiographic features in pts with and without history of PCR. respectively, 
included: ostial lesions (10% vs 6%. p < O.OOl), total occlusion (6% vs IO%, p < 0.001). 
ejection fraction (60.9% vs 56.6%, p < O.Ol), and LAD location (31% vs 41%, p < 0.001). 
Ilb/llla was used in 39% and 35% respectively (p < 0.001). In-hospital rates of cardiac 
events were low and similar. Kaplan-M&r estimates of events at 9 months an? shown 
(table). 
Conclusions: Despite similar in-hospital outcomes, patients with a history of prior PCR 
have a significantly lower event-free suwival at B-month follow-up. 
Kaplan-M&r Estimates of Cardiac Events at 9-month Follow-up 
Variable Prior PCR No Prior PCR 
Estimate (95% Cl) Estimate (95% Cl) 
P value 
Death 1.7(1.1-2.2) 1.2 (0.9-l .6) 0.059 
Ml 2.0 (1.4-2.5) 1.3 (1.0-l .6) 0.016 
CABG 7.6 (6.6-6.7) 3.2 (2.7-3.7) < 0.001 
Death or Ml 3.4 (2.6-4.1) 2.5 (2.0-2.9) 0.012 
Death, MI. or CABG 10.1 (6.9-11.4) 5.4 (4.7-6.0) < 0.001 
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Background: While plaque “eovascularization (NV) is associated with neointimal prolif- 
eration alter vessel wall injury, rupture of the external elastic lamina (EEL) may increase 
this angiogenic response. We tested the hypothesis that plaque NV is increased in coro- 
nary lesions with EEL rupture after balloon angioplasty in the swine model. 
Materials and Methods: Thirty-nine histological sections from ballooned coronary artery 
angioplasty segments were studied after 6 weeks of barotrauma. Rupture of EEL was 
defined as extensive tissue interruption along the media-adventitia interface on 40x light 
microscopy. Neovessels were defined as tubuloluminal anti-vWF positive capillaries rec- 
ognized in immunostained sections by light microscopy. Morphometric measurements 
wsre performed by computerized planimetry. 
Results: Plaque NV was increased in lesions with rupture of EEL (Table). Neointimal 
area was increased and lumen area was decreased in lesions with rupture of EEL 
(Table). EEL area was similar in both groups. Multiple regression analysis identified rup- 
ture of EEL as a” independent predictor for plaque NV (RR=l9.6; 95% Cl=2.4-37). 
Conclusion: Neovascularization is increased in coronary plaques with rupture of the 
external elastic lamina following vessel wall injury. This angiogenic response is associ- 
ated with increased neointima formation and reduced lumen ares. Thus, novel anti- 
angiogenic therapies may offer a” alternative option for the prevention of restenosis. 
